Utah Medical Products
UTMD60
$66.52arrow_drop_down1.04%-$0.69
UTMD60
$66.52
arrow_drop_down1.04%Performance History
| Key Stats | |
|---|---|
| Open | $67.31 |
| Prev. Close | $66.96 |
| EPS | 4.19 |
| Next Earnings Date | Jan 3, 2025 |
| Market Cap | $228.86M |
| LOW | HIGH | |
|---|---|---|
| Day Range | 57.00 | 68.28 |
| 52 Week Range | 57.00 | 87.99 |
| Ratios | |
|---|---|
| EPS | 4.19 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Utah Medical Products (UTMD)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Mr. Kevin L. Cornwell
- Headquarters
- Midvale
- Employees
- 186
- Exchange
- NASDAQ
Keep an eye on Utah Medical Products
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Utah Medical Products 's (UTMD) price per share?
The current price per share for Utah Medical Products (UTMD) is $66.52. The stock has seen a price change of -$0.7 recently, indicating a -1.05% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Utah Medical Products (UTMD)?
For Utah Medical Products (UTMD), the 52-week high is $87.99, which is 32.28% from the current price. The 52-week low is $57, the current price is 16.7% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Utah Medical Products (UTMD) a growth stock?
Utah Medical Products (UTMD) has shown an average price growth of -3.55% over the past three years. It has received a score of 27 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Utah Medical Products as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Utah Medical Products (UTMD) stock price performance year to date (YTD)?
As of the latest data, Utah Medical Products (UTMD) has a year-to-date price change of -20.32%. Over the past month, the stock has experienced a price change of 0%. Over the last three months, the change has been -0.61%. Over the past six months, the figure is -2.85%. Looking at a longer horizon, the five-year price change stands at -31.98%.
help
Is Utah Medical Products (UTMD) a profitable company?
Utah Medical Products (UTMD) has a net income of $16.64M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 48.47% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 37.54% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $50.22M, although specific revenue growth data is currently not available. The gross profit is $24.35M. Operating income is noted at $18.44M. Furthermore, the EBITDA is $20.92M.
help
What is the market capitalization of Utah Medical Products (UTMD)?
Utah Medical Products (UTMD) has a market capitalization of $228.86M. The average daily trading volume is 66.4, indicating the stock's liquidity and investor engagement.
News
May 28, 2024
Zacks Initiates Coverage of UTMD With Neutral Recommendation
May 24, 2024
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace
May 23, 2024
Top Stock Reports for Apple, Mastercard & Amgen
INVESTING
2 Beaten-Down Stocks That Could Be Ready to Soar
Apr 2, 2023
Dividend Champion, Contender, And Challenger Highlights: Week Of April 2
Jan 1, 2023
Dividend Champion, Contender, And Challenger Highlights: Week Of January 1